Cargando…
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides
Products of the Steroid Receptor RNA Activator gene (SRA1) have the unusual property to modulate the activity of steroid receptors and other transcription factors both at the RNA (SRA) and the protein (SRAP) level. Balance between these two genetically linked entities is controlled by alternative sp...
Autores principales: | Cooper, Charlton, Guo, Jimin, Yan, Yi, Chooniedass-Kothari, Shilpa, Hube, Florent, Hamedani, Mohammad K., Murphy, Leigh C., Myal, Yvonne, Leygue, Etienne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715257/ https://www.ncbi.nlm.nih.gov/pubmed/19483093 http://dx.doi.org/10.1093/nar/gkp441 |
Ejemplares similares
-
Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients
por: Yan, Yi, et al.
Publicado: (2009) -
Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer
por: Leygue, Etienne
Publicado: (2007) -
Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1
por: Kotan, Leman Damla, et al.
Publicado: (2016) -
Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation
por: Hubé, Florent, et al.
Publicado: (2011) -
Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers
por: Myal, Yvonne, et al.
Publicado: (2010)